AGCJ
ICPT

Alden Global Capital (Jersey)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Alden Global Capital (Jersey)’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-39,400
Closed -$6.15M – 29
2014
Q4 		$6.15M Buy
+39,400
New +$7.28M 1.48% 21

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alden Global Capital (Jersey)'s ICPT Position: Q1 2015 in Review

Alden Global Capital (Jersey) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2015, closing a stake of 39,400 shares — an estimated $6.15M sold.

Alden Global Capital (Jersey) first reported a position in ICPT in Q4 2014 and held it in 1 quarter. The position peaked at $6.15M in Q4 2014. 200 funds tracked by Wall St. Rank hold ICPT as of Q1 2015.

  • Alden Global Capital (Jersey) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Alden Global Capital (Jersey) sold 39,400 Intercept Pharmaceuticals, Inc. shares in Q1 2015, an estimated $6.15M.
  • Alden Global Capital (Jersey) first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 1 quarter.
  • Alden Global Capital (Jersey)'s Intercept Pharmaceuticals, Inc. position peaked at $6.15M in Q4 2014.
  • 200 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2015.

Based on Alden Global Capital (Jersey)'s 13F filing for Q1 2015.